Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

KROSKROS
Showing 8 of 18 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in KEROS THERAPEUTICS INC

TWO SIGMA INVESTMENTS, LP holds 246,649 shares of KROS (KEROS THERAPEUTICS INC), worth $2.6M as of 2026-Q2. The position was decreased (-32.2% shares). KROS represents 0.0% of TWO SIGMA INVESTMENTS, LP's portfolio.

Current Value

$2.6M

Current Shares

246,649

Total Value Change

+$2M

Total Shares Change

+236,327

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
246,649
-32.2%
$2.6M0.0%$10.70
0
2026-Q1
Increased
363,835
+14.3%
$4M0.0%$13.40
30
2025-Q4
Increased
318,439
+285.9%
$6.5M0.0%$20.27
44
2025-Q3
Increased
82,523
+510.3%
$1.3M0.0%$15.95
41
2025-Q2
Decreased
13,522
-78.3%
$180,5190.0%$13.49
0
2025-Q1
Increased
62,372
+85.3%
$635,5710.0%$10.79
38
2024-Q4
Increased
33,664
+226.1%
$532,9010.0%$15.64
39
2024-Q3
Decreased
10,322
-71.5%
$599,3990.0%$56.45
0

Other major holders of KROS: BlackRock Finance, Inc., RA CAPITAL MANAGEMENT, L.P., ALKEON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used